Literature DB >> 8165832

Effect of hepatocyte growth factor (HGF)/scatter factor (SF) on cell adhesion in gastric cancer.

A Tannapfel1, C Wittekind, E Tahara.   

Abstract

Hepatocyte Growth Factor (HGF)/Scatter Factor (SF) is a secretory glycoprotein from stromal fibroblasts which binds to the transmembrane c-met receptor. This receptor is expressed from a variety of tumors, including gastric carcinomas. To look for a possible paracrine loop between gastric cancer cells and their surrounding fibroblasts in gastric carcinoma, the effect of HGF/SF treatment on the morphology and the expression of cell adhesion molecules was examined. The cell line TMK-1, established from poorly differentiated gastric carcinoma, responded with scattering after HGF/SF treatment. We found that the observed morphological changes were accompanied with a reduced expression of E- and P-cadherin protein in these cells. In a cell line established from well differentiated gastric carcinoma, named MKN-28, neither scattering nor changes in cadherin expression could be detected. This results suggested, that HGF/SF is a regulator of cell adhesion via affecting E- and P-cadherin. Taking into account, that only cells from poorly differentiated gastric carcinoma cell lines responded in scattering after HGF/SF treatment, paracrine secreted HGF/SF may play an important role in the pathogenesis of these type of gastric carcinoma in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8165832

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  3 in total

Review 1.  MET genetic lesions in non-small-cell lung cancer: pharmacological and clinical implications.

Authors:  Michele Zorzetto; Simona Ferrari; Laura Saracino; Simona Inghilleri; Giulia M Stella
Journal:  Transl Lung Cancer Res       Date:  2012-09

2.  Primary human fibroblasts induce diverse tumor invasiveness: involvement of HGF as an important paracrine factor.

Authors:  T Iwazawa; H Shiozaki; Y Doki; M Inoue; S Tamura; S Matsui; T Monden; K Matsumoto; T Nakamura; M Monden
Journal:  Jpn J Cancer Res       Date:  1996-11

3.  Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma.

Authors:  T Fukuura; C Miki; T Inoue; K Matsumoto; H Suzuki
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.